OIP5 and cardiac hypertrophy: To evaluate the impact of OIP5‐AS1 on obesity‐induced alteration of myocardial structure in vivo, we examined the effect of inhibition of OIP5‐AS1 on HFD‐induced myocardial hypertrophy, fibrosis, and remodeling.